Intellia Therap (NTLA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec15

Leerink Analyst Reiterates Buy Rating on Intellia Therapeutics

15:39

Dec12

Intellia Therapeutics CEO John M. Leonard Disposes of Company Stock

21:10

Nov27

Intellia Therapeutics Receives 'Hold' Rating from 24 Firms

08:47

Nov14

Intellia Therapeutics Inc reports Q3 2025 financial results

04:16

Nov13

Multiple Firms Have Different Ratings and Price Targets for Intellia Therapeutics

13:54

Nov11

Evercore ISI Analyst Downgrades Intellia Therapeutics Rating

09:42

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 13.78 M, Net Income -101.32 M, EPS -0.9195

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 14.25 M, Net Income -101.26 M, EPS -0.9761

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 16.63 M, Net Income -114.33 M, EPS -1.1046

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change